To differentiate between cancer and cisplatin-induced effects, we used a transgenic mouse model of breast cancer expressing a large T-antigen on a C3 promoter (C3TAg) that exhibits the evolutionary spectrum of human breast cancer [28]. This evidence concerns the gene C3 and breast carcinoma.